cysteine has been researched along with Cardiovascular Stroke in 43 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (11.63) | 18.7374 |
| 1990's | 2 (4.65) | 18.2507 |
| 2000's | 19 (44.19) | 29.6817 |
| 2010's | 11 (25.58) | 24.3611 |
| 2020's | 6 (13.95) | 2.80 |
| Authors | Studies |
|---|---|
| Aghlmandi, S; Akhmedov, A; Bucher, HC; Carballo, D; Gencer, B; Hamm, CW; Klingenberg, R; Landmesser, U; Lüscher, TF; Mach, F; Matter, CM; Nanchen, D; Räber, L; Rodondi, N; von Eckardstein, A; Windecker, S | 1 |
| Cai, B; Chen, H; Gong, R; Li, S; Li, X; Ma, W; Ne, J; Song, R; Sun, H; Tian, Y; Wang, X; Xu, B; Xu, Y; Yang, F; Yu, Y; Zhang, T; Zhang, W; Zhao, L; Zhao, Y | 1 |
| Cao, N; Chen, Z; Guo, Y; Ji, X; Lei, Y; Li, B; Lin, J; Liu, Z; Mai, B; Meng, Y; Qiu, Y; Song, M; Tong, T; Wang, L; Wang, Q; Wei, Y; Wu, J; Xie, S; You, X | 1 |
| Li, H; Li, T; Shi, L; Wang, Q | 1 |
| Chang, HJ; Gong, B; Li, RS; Liu, C; Tian, CC; Wang, DJ; Xu, TS; Xue, YX; Yue, LJ; Zhou, Q; Zhu, XY | 1 |
| Amanakis, G; Fergusson, MM; Liu, C; McGinty, S; Molkentin, JD; Murphy, E; Sun, J | 1 |
| An, GP; Dong, B; Han, SF; Jin, Q; Li, XY; Lin, YM; Liu, MY; Meng, LB; Song, Y; Wang, SX; Zhang, HM | 1 |
| Castiglioni, L; Colazzo, F; Gelosa, P; Sironi, L; Tremoli, E | 1 |
| Ballantyne, LL; Funk, CD; Mewburn, JD; Ni, NC | 1 |
| Evangelista, AM; Ferlito, M; Kohr, MJ; Murphy, E; Steenbergen, C | 1 |
| Borges, CR; Breburda, C; Jensen, S; Nikolova, B; Rehder, DS; Schaab, MR; Sherma, ND; Yassine, H | 1 |
| Chen, Y; Ding, YJ; Luo, Y; Ma, SF; Pu, SX; Tao, BB; Wang, WW; Wang, ZF; Wu, HJ; Zhu, YC | 1 |
| Huang, C; Lin, S; Liu, H; Liu, X; Tran, BH; Wang, S; Zhang, Q; Zhu, YZ | 1 |
| Bormans, G; de Saint Hubert, M; Fonge, H; Ni, Y; Nuyts, J; Rattat, D; Reutelingsperger, C; Verbruggen, A; Vunckx, K | 1 |
| Ambler, SK; Hodges, YK; Horwitz, LD; Jones, GM; Long, CS | 1 |
| Padmanabhan, M; Prince, PS; Rajadurai, M | 1 |
| Darlin Quine, S; Sangeetha, T | 2 |
| Liu, HR; Mu, Q; Rose, P; Wang, Q; Zhu, YZ | 1 |
| Chen, CL; Chen, YR; Garg, V; Green-Church, KB; Hu, K; Kang, PT; Zhang, L | 1 |
| Chiuve, SE; Ma, J; Manson, JE; Page, JH; Rimm, EB; Selhub, J; Stampfer, MJ | 1 |
| Carru, C; Deiana, L; Scanu, B; Sotgia, S; Talanas, G; Terrosu, P; Zinellu, A | 1 |
| Campolo, J; Cozzi, L; De Maria, R; Marocchi, A; Parodi, O; Parolini, M; Patrosso, MC; Penco, S | 1 |
| Horwitz, LD | 1 |
| Imam, SK | 1 |
| Elikowski, W; Kwaśnikowski, P; Lewandowski, K; Rzeźniczak, M; Swierczyńska, A | 1 |
| Quine, SD; Sangeetha, T | 2 |
| Mainzen Prince, PS; Padmanabhan, M | 1 |
| Chuah, SC; Moore, PK; Zhu, YZ | 1 |
| Das, DK | 1 |
| Ninger, E; Pojer, J; Továrek, J | 1 |
| Edland, SD; Higaki, J; Ikegami, H; Kamino, K; Martin, GM; Miki, T; Nakura, J; Ogihara, T; Oshima, J; Rakugi, H; Ye, L | 1 |
| Cabral, AM; Mauad, H; Meyrelles, SS; Vasquez, EC | 1 |
| Berti, F; Bonazzi, A; Buccellati, C; Folco, G; Maclouf, J; Rossoni, G; Sala, A | 1 |
| Collen, D; De Maeyer, M; Demarsin, E; Jespers, L; Laroche, Y; Moreau, H; Sinnaeve, P; Van de Werf, F | 1 |
| Amarenco, P; Arveiler, D; Cambien, F; Elbaz, A; Evans, A; Gariepy, J; Grandchamp, B; Hetet, G; Kee, F; Morrison, C; Nicaud, V; Simon, A | 1 |
| Abbate, R; Brunelli, T; Fedi, S; Gensini, GF; Giusti, B; Marcucci, R; Pepe, G; Poli, D; Prisco, D | 1 |
| Horwitz, LD; Sherman, NA | 1 |
| Bassano, D; Foster, AB; Gagne, G; Grossman, ZD; Markarian, B; McAfee, JG; Richardson, R; Subramanian, G | 1 |
| Burk, RF | 1 |
| Kronrád, L; Petrboková, I; Vavrejn, B | 1 |
| Dioso, M; Hardy, P; Perkoff, GT; Vélez-Garciá, E | 1 |
4 review(s) available for cysteine and Cardiovascular Stroke
| Article | Year |
|---|---|
Role of the Cysteinyl Leukotrienes in the Pathogenesis and Progression of Cardiovascular Diseases.
Topics: Animals; Arachidonate 5-Lipoxygenase; Atherosclerosis; Cardiovascular Diseases; Cysteine; Humans; Leukotrienes; Myocardial Infarction | 2017 |
Bucillamine: a potent thiol donor with multiple clinical applications.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cardiac Surgical Procedures; Clinical Trials as Topic; Cysteine; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Ischemia; Liver; Liver Transplantation; Myocardial Infarction; Oxidative Stress; Reperfusion Injury | 2003 |
Molecular nuclear imaging: the radiopharmaceuticals (review).
Topics: Animals; Annexins; Antibodies, Monoclonal; Antigens; Apoptosis; Cysteine; Diagnostic Imaging; DNA; Fluorodeoxyglucose F18; Glycolysis; Humans; Indium Radioisotopes; Ligands; Lymphoma; Myocardial Infarction; Neoplasms; Octreotide; Organotechnetium Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Technetium; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 2005 |
Neural reflex regulation of arterial pressure in pathophysiological conditions: interplay among the baroreflex, the cardiopulmonary reflexes and the chemoreflex.
Topics: Animals; Baroreflex; Blood Pressure; Chemoreceptor Cells; Cysteine; Hypertension; Myocardial Infarction; Potassium Cyanide; Pressoreceptors; Rabbits; Rats; Serotonin | 1997 |
1 trial(s) available for cysteine and Cardiovascular Stroke
| Article | Year |
|---|---|
Polyethylene glycol-derivatized cysteine-substitution variants of recombinant staphylokinase for single-bolus treatment of acute myocardial infarction.
Topics: Acute Disease; Aged; Cysteine; Enzyme Stability; Fibrinolytic Agents; Half-Life; Humans; Metalloendopeptidases; Myocardial Infarction; Polyethylene Glycols; Recombinant Proteins | 2000 |
38 other study(ies) available for cysteine and Cardiovascular Stroke
| Article | Year |
|---|---|
Cysteine-Rich Angiogenic Inducer 61 Improves Prognostic Accuracy of GRACE (Global Registry of Acute Coronary Events) 2.0 Risk Score in Patients With Acute Coronary Syndromes.
Topics: Acute Coronary Syndrome; Biomarkers; C-Reactive Protein; Cysteine; Humans; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Registries; Risk Assessment; Risk Factors; Troponin T | 2021 |
Oxidant stress-sensitive circRNA Mdc1 controls cardiomyocyte chromosome stability and cell cycle re-entry during heart regeneration.
Topics: Animals; Animals, Newborn; Cell Cycle; Cell Cycle Proteins; Cell Proliferation; Chromosomal Instability; Cysteine; Heart; Mice; Myocardial Infarction; Myocytes, Cardiac; Oxidants; Regeneration; RNA, Circular | 2022 |
Cysteine-Based Redox-Responsive Nanoparticles for Fibroblast-Targeted Drug Delivery in the Treatment of Myocardial Infarction.
Topics: Animals; Cysteine; Disease Models, Animal; Fibroblasts; Fibrosis; Mice; Myocardial Infarction; Myocardium | 2023 |
Sensitively detecting endogenous homocysteine in human serum and cardiomyocytes with a specific fluorescent probe.
Topics: Cysteine; Fluorescent Dyes; Glutathione; HeLa Cells; Homocysteine; Humans; Myocardial Infarction; Myocytes, Cardiac; Spectrometry, Fluorescence | 2023 |
S‑allyl‑cysteine sulfoxide (alliin) alleviates myocardial infarction by modulating cardiomyocyte necroptosis and autophagy.
Topics: Animals; Apoptosis; Autophagy; Cell Survival; Cysteine; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Necroptosis; Receptor-Interacting Protein Serine-Threonine Kinases; Safrole; Signal Transduction | 2019 |
Cysteine 202 of cyclophilin D is a site of multiple post-translational modifications and plays a role in cardioprotection.
Topics: Acetylation; Animals; Calcium; Cysteine; Disease Models, Animal; Isolated Heart Preparation; Mice, Inbred C57BL; Mice, Transgenic; Mitochondria, Heart; Mitochondrial Permeability Transition Pore; Mutation; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Oxidation-Reduction; Oxidative Stress; Peptidyl-Prolyl Isomerase F; Protein Processing, Post-Translational | 2021 |
S-Nitrosylation of Akt by organic nitrate delays revascularization and the recovery of cardiac function in mice following myocardial infarction.
Topics: Adenoviridae; Amino Acid Sequence; Animals; Apolipoproteins E; Cell Movement; Cell Proliferation; Cysteine; HEK293 Cells; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mutation; Myocardial Infarction; Myocardial Revascularization; Neovascularization, Physiologic; Nitrates; Nitric Oxide; Nitroglycerin; Nitroprusside; Nitrosation; Proto-Oncogene Proteins c-akt | 2021 |
Multiple-site activation of the cysteinyl leukotriene receptor 2 is required for exacerbation of ischemia/reperfusion injury.
Topics: Animals; Capillary Permeability; Cysteine; Disease Models, Animal; Endothelial Cells; Humans; Leukocyte Rolling; Leukocytes; Leukotrienes; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Muscle, Skeletal; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Receptors, Leukotriene; Time Factors | 2014 |
S-nitrosylation of TRIM72 at cysteine 144 is critical for protection against oxidation-induced protein degradation and cell death.
Topics: Animals; Blotting, Western; Carrier Proteins; Cell Death; Cell Survival; Cysteine; Female; Ischemic Preconditioning; Male; Membrane Proteins; Mice, Inbred C57BL; Myocardial Infarction; Myocardial Reperfusion Injury; Nitric Oxide; Oxidation-Reduction; Proteolysis | 2014 |
Elevated plasma albumin and apolipoprotein A-I oxidation under suboptimal specimen storage conditions.
Topics: Apolipoprotein A-I; Chromatography, Liquid; Cryopreservation; Cysteine; Diabetes Mellitus, Type 2; Freezing; Humans; Male; Methionine; Myocardial Infarction; Oxidation-Reduction; Oxidative Stress; Prostatic Neoplasms; Serum Albumin; Specimen Handling; Spectrometry, Mass, Electrospray Ionization | 2014 |
Hydrogen Sulfide Targets the Cys320/Cys529 Motif in Kv4.2 to Inhibit the Ito Potassium Channels in Cardiomyocytes and Regularizes Fatal Arrhythmia in Myocardial Infarction.
Topics: Amino Acid Motifs; Animals; Arrhythmias, Cardiac; Cysteine; Disulfides; HEK293 Cells; Humans; Hydrogen Sulfide; Male; Mutation; Myocardial Infarction; Myocytes, Cardiac; Rats; Shal Potassium Channels | 2015 |
Cardioprotective effects and pharmacokinetic properties of a controlled release formulation of a novel hydrogen sulfide donor in rats with acute myocardial infarction.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cardiotonic Agents; Creatine Kinase; Cysteine; Delayed-Action Preparations; Electrocardiography; Glutathione; Hydrogen Sulfide; L-Lactate Dehydrogenase; Lipid Peroxidation; Male; Myocardial Infarction; Rats, Sprague-Dawley; Superoxide Dismutase | 2015 |
Preliminary in vivo evaluation of a novel 99mTc-labeled HYNIC-cys-annexin A5 as an apoptosis imaging agent.
Topics: Animals; Annexin A5; Apoptosis; Chemistry, Pharmaceutical; Cysteine; Drug Design; Liver; Mice; Models, Chemical; Myocardial Infarction; Organotechnetium Compounds; Rabbits; Sulfhydryl Compounds; Tomography, Emission-Computed, Single-Photon | 2008 |
Prolonged administration of a dithiol antioxidant protects against ventricular remodeling due to ischemia-reperfusion in mice.
Topics: Animals; Antioxidants; Body Weight; Cysteine; Cytokines; Female; Fetus; Gene Expression; Heart Function Tests; Mice; Mice, Inbred C57BL; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nuclease Protection Assays; Organ Size; Pregnancy; Ventricular Dysfunction, Left; Ventricular Remodeling | 2008 |
Preventive effect of S-allylcysteine on membrane-bound enzymes and glycoproteins in normal and isoproterenol-induced cardiac toxicity in male Wistar rats.
Topics: Adenosine Triphosphatases; alpha-Tocopherol; Animals; Antioxidants; Blood Proteins; Cell Membrane; Creatine Kinase, MB Form; Cysteine; Glycoproteins; Iron; Iron-Binding Proteins; Isoproterenol; Male; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Uric Acid | 2008 |
Preventive effect of S-allyl cysteine sulphoxide (Alliin) on mitochondrial dysfunction in normal and isoproterenol induced cardiotoxicity in male Wistar rats: a histopathological study.
Topics: Animals; Cysteine; Isoproterenol; Male; Mitochondria; Mitochondrial Diseases; Mitochondrial Proteins; Myocardial Infarction; Myocardium; Rats; Rats, Wistar | 2009 |
S-propargyl-cysteine protects both adult rat hearts and neonatal cardiomyocytes from ischemia/hypoxia injury: the contribution of the hydrogen sulfide-mediated pathway.
Topics: Animals; Animals, Newborn; Cell Hypoxia; Cell Survival; Cystathionine gamma-Lyase; Cysteine; Disease Models, Animal; Hydrogen Sulfide; Male; Myocardial Infarction; Myocardial Ischemia; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Up-Regulation | 2009 |
Peroxynitrite-mediated oxidative modifications of complex II: relevance in myocardial infarction.
Topics: Amino Acid Sequence; Animals; Cell Hypoxia; Cyclic N-Oxides; Cysteine; Disulfides; Electron Transport Complex II; Flavin-Adenine Dinucleotide; Humans; Molecular Sequence Data; Molecular Weight; Muscle Cells; Myocardial Infarction; Oxidation-Reduction; Peroxynitrous Acid; Protein Subunits; Rats; Rats, Sprague-Dawley; Tyrosine | 2010 |
Plasma total cysteine and total homocysteine and risk of myocardial infarction in women: a prospective study.
Topics: Adult; Case-Control Studies; Cysteine; Female; Homocysteine; Humans; Middle Aged; Myocardial Infarction; Risk Factors | 2010 |
Low density lipoprotein S-homocysteinylation is increased in acute myocardial infarction patients.
Topics: Acute Coronary Syndrome; Aged; Apolipoproteins B; Biomarkers; Cardiovascular Diseases; Cysteine; Electrophoresis, Capillary; Female; Homocysteine; Humans; Italy; Lipoproteins, LDL; Male; Middle Aged; Myocardial Infarction; Risk Factors; Sulfhydryl Compounds | 2012 |
Paraoxonase 1 L55M, Q192R and paraoxonase 2 S311C alleles in atherothrombosis.
Topics: Alleles; Aryldialkylphosphatase; Cysteine; Female; Genetic Predisposition to Disease; Genotype; Glutathione; Homocysteine; Humans; Hypertension; Ischemic Attack, Transient; Lipid Peroxidation; Lipids; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Oxidative Stress; Polymorphism, Single Nucleotide; Risk Factors; Stroke; Thrombosis | 2013 |
The prevalence of C807T mutation of glycoprotein Ia gene among young male survivors of myocardial infarction: a relation with coronary angiography results.
Topics: Adult; Alanine; Case-Control Studies; Coronary Angiography; Cysteine; Gene Expression; Gene Frequency; Genetic Predisposition to Disease; Humans; Integrin alpha2; Male; Middle Aged; Mutation; Myocardial Infarction; Polymorphism, Genetic; Threonine | 2005 |
Antilipoperoxidative and antioxidant effects of S-allyl cysteine sulfoxide on isoproterenol-induced myocardial infarction in Wistar rats.
Topics: Animals; Antioxidants; Creatine Kinase; Cysteine; Isoproterenol; Lipid Peroxidation; Male; Myocardial Infarction; Rats; Rats, Wistar | 2006 |
S-allylcysteine ameliorates isoproterenol-induced cardiac toxicity in rats by stabilizing cardiac mitochondrial and lysosomal enzymes.
Topics: Adrenergic beta-Agonists; alpha-Tocopherol; Animals; Antineoplastic Agents; Cysteine; Electrocardiography; Heart Diseases; Isoproterenol; Lysosomes; Male; Mitochondria, Heart; Myocardial Infarction; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances | 2007 |
Preventive effect of S-allyl cysteine sulfoxide (alliin) on lysosomal hydrolases and membrane-bound ATPases in isoproterenol-induced myocardial infarction in Wistar rats.
Topics: Adenosine Triphosphatases; Animals; Cell Membrane; Cysteine; Enzyme Activation; Hydrolases; Isoproterenol; Lysosomes; Male; Myocardial Infarction; Rats; Rats, Wistar | 2007 |
S-allylcysteine mediates cardioprotection in an acute myocardial infarction rat model via a hydrogen sulfide-mediated pathway.
Topics: Animals; Cardiotonic Agents; Cystathionine gamma-Lyase; Cysteine; Garlic; Humans; Hydrogen Sulfide; Male; Myocardial Infarction; Plant Extracts; Rats; Rats, Wistar; Signal Transduction | 2007 |
Hydrogen sulfide preconditioning by garlic when it starts to smell.
Topics: Animals; Cardiotonic Agents; Cysteine; Garlic; Humans; Hydrogen Sulfide; Myocardial Infarction; Plant Extracts; Rats; Signal Transduction | 2007 |
Protective effect of S-allyl cysteine sulphoxide (alliin) on glycoproteins and hematology in isoproterenol induced myocardial infarction in male Wistar rats.
Topics: Adrenergic beta-Agonists; Animals; Blood Cell Count; Blood Chemical Analysis; Blood Coagulation; Cardiotonic Agents; Cysteine; Glycoproteins; Isoproterenol; Male; Myocardial Infarction; Myocardium; Rats; Rats, Wistar | 2008 |
Diagnosis of myocardial infarction by means of activated creatine phosphokinase.
Topics: Aspartate Aminotransferases; Clinical Enzyme Tests; Creatine Kinase; Cysteine; Humans; L-Lactate Dehydrogenase; Myocardial Infarction | 1967 |
Association of a polymorphic variant of the Werner helicase gene with myocardial infarction in a Japanese population.
Topics: Adult; Age of Onset; Aged; Arginine; Case-Control Studies; Cysteine; Diabetes Mellitus, Type 2; Female; Genetic Variation; Homozygote; Humans; Japan; Male; Middle Aged; Mutation; Myocardial Infarction; Polymorphism, Genetic; Werner Syndrome | 1997 |
Monoclonal anti-CD18 antibody prevents transcellular biosynthesis of cysteinyl leukotrienes in vitro and in vivo and protects against leukotriene-dependent increase in coronary vascular resistance and myocardial stiffness.
Topics: Animals; Antibodies, Monoclonal; Calcimycin; CD18 Antigens; Cysteine; Endothelium, Vascular; Heart; In Vitro Techniques; Inflammation Mediators; Leukotrienes; Myocardial Infarction; Neutrophils; Rabbits; Vascular Resistance | 2000 |
Association studies between haemochromatosis gene mutations and the risk of cardiovascular diseases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arteriosclerosis; Aspartic Acid; Brain Infarction; Cardiovascular Diseases; Case-Control Studies; Cysteine; Female; France; Genetic Predisposition to Disease; Genotype; Hemochromatosis; Hemochromatosis Protein; Histidine; Histocompatibility Antigens Class I; HLA Antigens; Humans; Male; Membrane Proteins; Middle Aged; Mutation; Myocardial Infarction; Northern Ireland; Polymorphism, Genetic; Prevalence; Prospective Studies; Tyrosine; Ultrasonography; United Kingdom | 2001 |
The role of cysteine and homocysteine in venous and arterial thrombotic disease.
Topics: Adult; Aged; Aged, 80 and over; Arteries; Cysteine; Fasting; Female; Homocysteine; Humans; Male; Methionine; Middle Aged; Myocardial Infarction; Reference Values; Thrombosis; Venous Thrombosis | 2001 |
Bucillamine prevents myocardial reperfusion injury.
Topics: Animals; Cells, Cultured; Collateral Circulation; Coronary Circulation; Cysteine; Dogs; Dose-Response Relationship, Drug; Hydrogen Peroxide; Kinetics; L-Lactate Dehydrogenase; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Rats; Single-Blind Method; Sulfhydryl Compounds; Tiopronin | 2001 |
Myocardial uptake (rabbit) of six 99mTc-tagged pharmaceuticals and 85Sr after vasopressin-induced necrosis.
Topics: Animals; Citrates; Cysteine; Diphosphates; Diphosphonates; Disease Models, Animal; Myocardial Infarction; Rabbits; Radionuclide Imaging; Strontium Radioisotopes; Sugar Acids; Technetium; Vasopressins | 1977 |
Selenium and myocardial infarction.
Topics: Cysteine; Humans; Myocardial Infarction; Selenium; Selenocysteine; Selenomethionine | 1989 |
Possibilities of scintigraphic detection of tumours and damaged tissues with the aid of radioactive mercury compounds.
Topics: Animals; Carcinoma 256, Walker; Carcinosarcoma; Cysteine; Dogs; Male; Mercury Isotopes; Mice; Myocardial Infarction; Neoplasms, Experimental; Radionuclide Imaging; Rats; Sarcoma, Yoshida | 1972 |
Cysteine-stimulated serum creatine phosphokinase: unexpected results.
Topics: Adult; Alcoholic Intoxication; Blood Chemical Analysis; Creatine Kinase; Cysteine; Diabetic Ketoacidosis; Diagnosis, Differential; Female; Humans; Lung Diseases; Male; Middle Aged; Muscular Diseases; Myocardial Infarction | 1966 |